INMB
INmune Bio (INMB)
$94
About INmune Bio (INMB)
INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.
Details
Daily high
$1.94
Daily low
$1.84
Price at open
$1.86
52 Week High
$2.85
52 Week Low
$1.09
Market cap
50.5M
Dividend yield
0.00%
Volume
244,596
Avg. volume
561,201
P/E ratio
-1.12
INmune Bio News
Details
Daily high
$1.94
Daily low
$1.84
Price at open
$1.86
52 Week High
$2.85
52 Week Low
$1.09
Market cap
50.5M
Dividend yield
0.00%
Volume
244,596
Avg. volume
561,201
P/E ratio
-1.12